FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/21/2024
Back to search
Official data from USPTO
SORTAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
05/21/2024
Trademark type
Word
Nice classes
5, 10
Filing date
06/22/2022
Registration date
01/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2024
Last transaction
01/30/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DK
Examiner
LATTUCA, FRANK
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
D. A. (pessoa física)
Representatives
JENNIFER A. VAN KIRK LEWIS ROCA ROTHGERBER CHRISTIE LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biochemical preparations for medical use for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; chemical preparations for medical purposes neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; biological preparations for medical purposes for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; chemical reagents for medical use for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; medical preparations in the form of tabletscapsulessolutionspowders for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; protein synthesis inhibitors being chemical substances and compounds for medical use for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; diagnostic preparations and materials namely medical strips
Class 10
Medical apparatus and instrumentsnamely inhalerspumpsdispensers; Medical instrumentsnamely inhalerspumpsdispensers; diagnosticexamination and monitoring equipment for medical purposesnamely medical strips; all of the aforementioned goods not relating to the field of vascular and/or cardiovascular diseases
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/01/2024
FIMP
FINAL DISPOSITION PROCESSED
05/01/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/30/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/14/2023
PUBO
PUBLISHED FOR OPPOSITION
11/14/2023
GPNX
NOTIFICATION PROCESSED BY IB
11/13/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/25/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/30/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/30/2023
RFNP
REFUSAL PROCESSED BY IB
06/26/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2023
RFRR
REFUSAL PROCESSED BY MPU
06/05/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/17/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/17/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/17/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/17/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/17/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/17/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/08/2023
CNRT
NON-FINAL ACTION WRITTEN
04/07/2023
DOCK
ASSIGNED TO EXAMINER
04/04/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/19/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/15/2022
Continuous trademark protection
Get notified about every new filing that threatens SORTAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.